Skip to main navigation Skip to search Skip to main content

Localization and treatment of transformed tissues using the photodynamic sensitizer 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a

  • Kinya Furukawa
  • , Hideki Yamamoto
  • , David H. Crean
  • , Harubumi Kato
  • , Thomas S. Mang
  • Roswell Park Cancer Institute
  • Tokyo Medical University
  • University Health Network

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Abstract

Background and Objective: Photofrin is the photosensitizer currently used in most clinical trials examining the efficacy of photodynamic therapy (PDT) for the treatment and/or palliation of neoplasia. Although this drug has been shown to be efficacious in many of these trials, it possesses less than ideal qualities for use in a systemically administered photosensitizer. A new photosensitizer, 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH), was developed for PDT. HPPH possesses more rapid clearance from skin and greater cytotoxicity per drug dose than Photofrin. The aims of this study were to: (1) examine the uptake and retention of HPPH in tissues undergoing malignant transformation using laser-induced fluorescence, and (2) evaluate the efficacy of HPPH and 665 nm light in treating carcinogen-induced tumors of the hamster buccal cheek pouch. Study Design/Materials and Methods: The model of tissue transformation was the carcinogen (9,10-dimethyl-1,2- benzanthracene)-induced premalignant and malignant lesions of the hamster buccal cheek pouch. Following induction of the specific transformation stages, hamsters were injected intraperitoneally with 0.5 mg/kg HPPH. Subsequently, the buccal mucosa was examined for fluorescence at various times up to 72 hours after photosensitizer injection. Results: Uptake studies of HPPH showed highest fluorescence levels in tissues 48 hours after HPPH injection. Fluorescence levels of tissues increased significantly as follows. Normal < dysplasia < papillomas < squamous cell carcinomas. Carcinogen- induced tumors in 14 hamsters were treated with surface illuminations of red light (665 nm) via fiber optics coupled to an argon-ion pumped dye laser 48 hours after intraperitoneal injection with either 0.5 or 1.0 mg/kg HPPH. Complete necrosis of tumor tissues 7 days following PDT was observed in 57% (4/7) with 0.5 mg/kg and 86% (6/7) with 1.0 mg/kg HPPH. Conclusions: It appears that HPPH may be a promising photosensitizer for the detection and photodynamic treatment of transformed tissues.

Original languageEnglish
Pages (from-to)157-166
Number of pages10
JournalLasers in Surgery and Medicine
Volume18
Issue number2
DOIs
StatePublished - 1996

Keywords

  • argon dye laser
  • diagnosis
  • hamster buccal cheek pouch
  • HPPH
  • laser-induced fluorescence
  • photodynamic therapy
  • Photofrin
  • photosensitization
  • squamous cell carcinoma

Fingerprint

Dive into the research topics of 'Localization and treatment of transformed tissues using the photodynamic sensitizer 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a'. Together they form a unique fingerprint.

Cite this